Internal Metabolomic Biomarker Exposome and Developmental Disorders (IMBEDD) (Q20): Difference between revisions
Changed label, description and/or aliases in en, and other parts |
Changed an Item |
||
| Property / geographic location | |||
| Property / geographic location: United States of America / rank | |||
Normal rank | |||
Revision as of 23:37, 19 December 2024
The MARBLES (Markers of Autism Risk in Babies: Learning Early Signs) prospective study of over 450 high-risk pregnancies recruits mothers who have a child with confirmed ASD and are either planning a pregnancy or are pregnant with another child, in o
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Internal Metabolomic Biomarker Exposome and Developmental Disorders (IMBEDD) |
The MARBLES (Markers of Autism Risk in Babies: Learning Early Signs) prospective study of over 450 high-risk pregnancies recruits mothers who have a child with confirmed ASD and are either planning a pregnancy or are pregnant with another child, in o |
Statements
#R01ES020392; NIEHS P01ES011269; EPA RD82938801;NIEHS (P01ES011269) and EPA (RD82938801). EPA 83543201;R01ES025574 ; R01ES028089; R21ES025551;P01ES011268-13S2) under PA-15-123 DOD: AR110194.
0 references